Sebastian W. Fuchs | Lab Head Bioassay Automation
Merck Healthcare KGaA

Sebastian W. Fuchs, Lab Head Bioassay Automation, Merck Healthcare KGaA

I earned my PhD in peptide and polyketide natural product research from Goethe University Frankfurt, followed by a postdoctoral position at ETH Zurich specializing in proteinogenic natural products. In 2018, I joined Merck in Darmstadt, focusing initially on quantitative bioanalysis. Since 2021, I have served as the lab head for HTS bioassay automation at Merck Healthcare, and since September 2023, I have also taken on the role of temporary lab head for high-throughput Mass Spectrometry.


Day 1 (26th June) @ 15:15

Accelerating Merck's DMTA cycle with Genedata automation: data load, QC, & report

To expedite Merck KGaA, Darmstadt, Germany's small molecule Design, Make, Test, and Analyze (DMTA) cycle, our presentation emphasizes automating data flow using Genedata Screener. While both laboratory process automation and data flow automation can significantly accelerate the DMTA cycle, our focus here is specifically on enhancing efficiency through the automation of data flow, thereby streamlining operations, and reducing cycle times.

This presentation will cover multiple facets: data ingestion into Screener, automated plate mapping, quality control of assay data, dose-response curve classification, and automated reporting into Merck’s company database.

last published: 14/Jun/24 11:25 GMT

back to speakers



For conference production and speaking opportunites:

Für die Produktion von Konferenzen und die Möglichkeit, Vorträge zu halten: 

For sponsorship and exhibition opportunities: